Last reviewed · How we verify
NCT04261088
Assisted Suicide in Switzerland
trial in Assisted Suicide in 25 participants. Participants enrolled and being followed up; not accepting new ones.
31 January 2027
Quick facts
| Lead sponsor | National Institutes of Health Clinical Center (CC) |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 3 February 2020 |
| Primary completion | 31 January 2027 |
| Estimated completion | 31 January 2027 |
| Sites | 1 location across United States |
Conditions studied
- Assisted Suicide — all drugs for Assisted Suicide →
Sponsor
National Institutes of Health Clinical Center (CC)
Who can join
18 and older, any sex, with Assisted Suicide. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts. Objective: To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice. Eligibility: Swiss experts in the field of assisted suicide Design: The study includes 25 interviews that have already been conducted. The participants were: * academics * doctors and others in medical care * a government official * representatives of right-to-die societies. Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04261088
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other National Institutes of Health Clinical Center (CC) trials
Trials by the same sponsor.
- NCT06998134 — Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults · recruiting
- NCT05473429 — Characterization of Nociception Phenotype in Individuals With Intellectual Disability · NA · recruiting
- NCT07295795 — Blood Sampling Pre- and Post-Propofol Administration to Characterize the Blood Proteome Using Different Research Assays · recruiting
- NCT05663320 — A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adu · NA · withdrawn
- NCT06778252 — UrbanHEAT: Health Behaviors, Outcomes, and Disparities in Individually Experienced Temperature Across an Urban Community · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04261088 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institutes of Health Clinical Center (CC)
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04261088.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing